Abstract:Cell‐penetrating peptides (CPPs), first identified in HIV a few decades ago, deserved great attention in the last two decades; especially to support the penetration of anticancer drug means. In the drug delivery discipline, they have been involved in various approaches from mixing with hydrophobic drugs to the use of genetically conjugated proteins. The early classification as cationic and amphipathic CPPs has been extended to a few more classes such as hydrophobic and cyclic CPPs so far. Developing potential sequences utilized almost all methods of modern science: choosing high‐efficiency peptides from natural protein sequences, sequence‐based comparison, amino acid substitution, obtaining chemical and/or genetic conjugations, in silico approaches, in vitro analysis, animal experiments, etc. The bottleneck effect in this discipline reveals the complications that modern science faces in drug delivery research. Most CPP‐based drug delivery systems (DDSs) efficiently inhibited tumor volume and weight in mice, but only in rare cases reduced their levels and continued further processes. The integration of chemical synthesis into the development of CPPs made a significant contribution and even reached the clinical stage as a diagnostic tool. But constrained efforts still face serious problems in overcoming biobarriers to reach further achievements. In this work, we reviewed the roles of CPPs in anticancer drug delivery, focusing on their amino acid composition and sequences. As the most suitable point, we relied on significant changes in tumor volume in mice resulting from CPPs. We provide a review of individual CPPs and/or their derivatives in a separate subsection.

Furin Substrate As a Novel Cell-Penetrating Peptide: Combining a Delivery Vector and an Inducer of Cargo Release

Cell Penetrating Peptide-Based Self-Assembly for PD-L1 Targeted Tumor Regression.

A Novel Human Derived Cell-Penetrating Peptide in Drug Delivery

Endoprotease-mediated intracellular protein delivery using nanocapsules.

A high hydrophobic moment arginine-rich peptide screened by a machine learning algorithm enhanced ADC antitumor activity

Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.

Recent Progress of Cell-Penetrating Peptides As New Carriers for Intracellular Cargo Delivery.

Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo

Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs

Tumor Imaging by Means of Proteolytic Activation of Cell-Penetrating Peptides

Penetrating peptides: Applications in drug delivery

[Development of Cell-Penetrating Peptides As Vectors for Drug Delivery].

Cell penetrating peptides: Highlighting points in cancer therapy

In Vivo Characterization Of Activatable Cell Penetrating Peptides For Targeting Protease Activity In Cancer

Design of a new pH-activatable cell-penetrating peptide for drug delivery into tumor cells.

Enzymatic Activation of Cell-Penetrating Peptides in Self-Assembled Nanostructures Triggers Fibre-to-micelle Morphological Transition

Activable Cell-Penetrating Peptide Conjugated Prodrug for Tumor Targeted Drug Delivery

Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules

The role of cell‐penetrating peptides in potential anti‐cancer therapy

Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.

P-Sulfonatocalix[4]arene turns peptide aggregates into an efficient cell-penetrating peptide